[LGND] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 40.64%
YoY- 31.95%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 14,737 13,005 9,580 11,651 13,635 6,375 5,742 87.13%
PBT 2,008 2,025 3,804 1,370 950 -52 -3,728 -
Tax 139 60 110 66 -1,636 142 338 -44.60%
NP 1,869 1,965 6,091 1,495 1,063 -194 -2,267 -
Tax Rate -6.92% -2.96% -2.89% -4.82% 172.21% - - -
Total Cost 12,868 11,040 3,489 10,156 12,572 6,569 8,009 37.06%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 12.68 15.11 63.58 12.83 7.80 -3.04 -39.48 -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS 0.09 0.10 0.30 0.07 0.05 -0.01 -0.11 -
EPS Diluted 0.09 0.09 0.30 0.07 0.05 -0.01 -0.11 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.